Health care price regulation is undemocratic
The Biden administration recently announced that it will use taxpayer dollars to “stabilize” Medicare Part D (prescription drug coverage) premiums.
Chairman Comer Calls on PBM Executives to Correct Hearing Testimony
The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.
AMA President Urges Congress To Prioritize Physician Pay Relief, Prior Authorization Reform
The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.
States force drugmakers to keep selling cheaper meds under federal program
The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.
FDA approves Illumina’s tumor biomarker test as a pan-cancer companion diagnostic
The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.
These middlemen say they keep drug prices low. California lawmakers don’t buy it
The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.
Health care consolidation: Crippling rise of costs is hidden in plain sight
The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.
Feds Killed Plan To Curb Medicare Advantage Overbilling After Industry Opposition
The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.
New Medicare Codes Seen Elevating Role of Patient Navigators
The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.
Pfizer joins direct-to-consumer drug sales
The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.
